Skip to main content

Linguamatics Moves UK Headquarters to Larger Facility

Premium

Linguamatics said this week that it is moving its UK-based headquarters to a new office located at the Cambridge Science Park.

The privately held company said its move to the new location was motivated by “consistent financial performance,” including “healthy profit margins, strong revenue growth from software sales and consultancy services, plus a strong balance sheet.”

Roger Hale, Linguamatics' cofounder and CEO, said in a statement that the new location will give the company the space it needs to “expand our product development and business teams to facilitate our planned growth into new areas.”

Linguamatics said it also expects to move its US office in Newton, Mass., to a larger space, although it has not disclosed where the new location will be.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.